Wasserman, Richard L <br/><br/>
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency.  [electronic resource] 

 -  Journal of clinical immunology  Aug 2012 
 - 663-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2592 
<br/><br/><label>Standard No.: </label>10.1007/s10875-012-9656-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Agammaglobulinemia--therapy<br/>Aged<br/>Bacterial Infections--immunology<br/>Child<br/>Common Variable Immunodeficiency--therapy<br/>Female<br/>Genetic Diseases, X-Linked--therapy<br/>Humans<br/>IgG Deficiency--genetics<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Male<br/>Middle Aged<br/>Young Adult